ELOVL7 antibody
Principal name
ELOVL7 antibody
Alternative names for ELOVL7 antibody
Elongation of very long chain fatty acids protein 7, 3-keto acyl-CoA synthase ELOVL7
Ncbi ID
NP_001098028, NP_001098028.1, NP_079206, ADR83129.1, NM_001104558, NM_024930, NP_083277.3, NM_029001
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Paraffin Sections (P), Western blot / Immunoblot (WB)
Background of ELOVL7 antibody
- Kit Component:
- - KN305174G1, Elovl7 gRNA vector 1 in pCas-Guide vector
- KN305174G2, Elovl7 gRNA vector 2 in pCas-Guide vector
- KN305174D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010)
Tamura, K., et al. Cancer Res. 69(20):8133-8140 (2009)
Lehner, R., et al. Prog. Lipid Res. 35(2):169-201 (1996)
Human Pancreas: Formalin-Fixed, Paraffin-Embedded (FFPE)
Western blot analysis in mouse lung tissue lysates (35ug/lane) using ELOVL7 antibody Cat.-No. AP51423PU-N (C-term). This demonstrates the ELOVL7 antibody detected the ELOVL7 protein (arrow).
Human HepG2; WB Suggested Anti-ELOVL7 Antibody Titration: 1.25ug/ml. Positive Control: HepG2 cell lysate; ELOVL7 antibody - N-terminal region (ARP49908_T100) in Human HepG2 cells using Western Blot
Western blot analysis of ELOVL7 in human liver tissue lysate with ELOVL7 antibody at 1 ug/mL.
Immunohistochemistry of ELOVL7 in human liver tissue with ELOVL7 antibody at 5 ug/mL.
Immunofluorescence of ELOVL7 in human liver tissue with ELOVL7 antibody at 20 ug/mL.
WB Suggested Anti-ELOVL7 Antibody Titration: 1.25 ug/ml; Positive Control: HepG2 cell lysate
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA306939 | ELOVL7 antibody |
||||||
| Rabbit Polyclonal ELOVL7 Antibody | |||||||
 |
Rabbit | IgG | Aff - Purified | Hu, Ms | E, P, WB |
0.1 mg /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
 +2 additional images |
|||||||
| AP23511PU-N | ELOVL7 (N-term) antibody |
||||||
 |
Rabbit | Hu, Ms | E, P, WB |
50 µg /
€425.00
|
|||
| OriGene Technologies GmbH | |||||||
| AP51423PU-N | ELOVL7 (C-term) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu, Ms | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY410968 | ELOVL7 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY426203 | ELOVL7 overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC225384L2V | Lenti ORF particles, ELOVL7 (mGFP-tagged) - Human ELOVL fatty acid elongase 7 (ELOVL7), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,020.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR217050L2V | Lenti ORF particles, Elovl7 (GFP-tagged) - Mouse ELOVL family member 7, elongation of long chain fatty acids (yeast) (Elovl7), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR217050L1V | Lenti ORF particles, Elovl7 (Myc-DDK-tagged) - Mouse ELOVL family member 7, elongation of long chain fatty acids (yeast) (Elovl7), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
